Aurinia Pharmaceuticals Q1 EPS $0.25 Beats $0.19 Estimate, Sales $77.705M Beat $77.390M Estimate

Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly earnings of $0.25 per share which beat the analyst consensus estimate of $0.19 by 31.58 percent. This is a 56.25 percent increase over earnings of $0.16 per share from the same period last year. The company reported quarterly sales of $77.705 million which beat the analyst consensus estimate of $77.390 million by 0.41 percent. This is a 24.40 percent increase over sales of $62.465 million the same period last year.